Transforming growth factor‐beta (TGF‐β) plays a dual role in tumor progression, initially acting as a tumor suppressor in early‐stage disease by inhibiting cell proliferation, but later promoting cancer progression by fostering an immunosuppressive microenvironment and inducing epithelial‐mesenchymal transition (EMT) [45]. The gene discussed is TGFB1; the disease is cancer.